Epidemiological and Histopathological Assessment of Corneal Dystrophies Leading to Corneal Transplantation by Nozarian, Zohreh et al.
Journal of Ophthalmic and Optometric Sciences. Volume 2, Number 2, Spring 2018.10
This work is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs (CC BY-NC-ND)
Original Article
Epidemiological and Histopathological 
Assessment of Corneal Dystrophies Leading to 
Corneal Transplantation
Zohreh Nozarian 1 , MD ; Vahid Mehrtash 2 , MD ; Fahimeh Asadi-Amoli 1 , MD ; 
Mohammad Soleimani *3, MD ; Seyed Ali Tabatabaei 3 , MD ; Abdollah Hadi 3 , MD
1. Department of Pathology, Tehran University of Medical Sciences, Tehran, Iran.
2. School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
3. Ocular Trauma and Emergencies Department, Farabi Eye Hospital, Tehran University of 
Medical Sciences, Tehran, Iran.
*Corresponding author: Mohammad Soleimani
E-mail: Soleimani_md@yahoo.com
How to cite this article:  Nozarian Z, Mehrtash V, Asadi-Amoli F, Soleimani M, Tabatabaei SA, 
Hadi A. Epidemiological and Histopathological Assessment of Corneal Dystrophies Leading to 
Corneal Transplantation . Journal of Ophthalmic and Optometric Sciences . 2018;2(2):10-6.
Article Notes:
Received: Oct. 3, 2017
Received in revised form: Jan. 
11, 2018
Accepted: Mar. 17, 2018









Purpose: To carry out an epidemiological assessment of corneal 
dystrophies leading to corneal transplantation and to determine 
different subtype frequencies.
Patients and Methods: In this retrospective study, pathological 
records of patients who had corneal transplantations other than 
endothelial keratoplasty between the years 2002 and 2014 were 
examined. To determine different subtype frequencies when corneal 
dystrophies led to corneal transplantation the IC3D classification of 
corneal dystrophies-edition 2 was used.
Results: Of the 5867 eyes undergoing corneal transplant surgery 
during the study timeframe, 239 (4.07 %) belonged to patients with 
corneal dystrophy. The most common age group was between 20 
and 29 years (n = 57 ; 23.8 %). Macular corneal dystrophy was the 
most frequent corneal dystrophy subtype (n = 117 ; 49 %). Patients 
with epithelial and sub-epithelial dystrophies were significantly 
younger, and patients with Fuchs endothelial corneal dystrophy 
and lattice corneal dystrophy were the oldest age group when 
undergoing corneal transplantation. 
Conclusions: Based on our findings macular corneal dystrophy was 
the most common corneal dystrophy subtype in patients scheduled 
for corneal transplantations other than endothelial keratoplasty.    
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Introduction
Impaired vision due to corneal pathology is 
a challenging issue, especially in developing 
countries 1. Corneal opacity can result from 
trauma, inflammation, infection, metabolic 
and genetic disorders 2. Corneal dystrophy 
(CD) has high importance as a genetic 
disorder causing corneal opacities resulting 
in corneal transplantation surgery 3-6. CD is 
a corneal alteration which is mostly bilateral, 
symmetric and not associated with systemic, 
inflammatory and environmental factors 7. 
Aside from congenital hereditary endothelial 
dystrophy (CHED), which is a congenital 
disorder, and posterior polymorphous corneal 
dystrophy (PPCD), which can present itself 
as a congenital disease, other types of CD 
usually appear during the first and second 
decades of life 8. CD primarily involves one 
layer of the cornea in the central area and 
often progresses slowly 9. Corneal dystrophies 
are categorized into epithelial, sub-epithelial, 
epithelial-stromal, stromal and endothelial 
types based on the affected cellular layer 8,10. 
Previously, clinical and histopathological 
characteristics of CD were the only tools 
available for distinguishing the different types 
and classifying this disease 11. Using these 
two features alone, without putting to use 
the genetic attributes of the disease, causes 
some limitations in classification. Nowadays 
molecular genetics techniques have made it 
possible to reach a more precise classification 
and have significantly helped us in diagnosing 
the atypical forms of the disease 12,13. The 
diagnosis of CD is based on clinical signs 
and symptoms and confirming the diagnosis 
is via genetic and histopathological studies 7. 
Determining CD’s pathological attributions 
paves the way for health planners to assess 
the health needs of these patients and guide 
ophthalmologists about the types of CD which 
should be considered in their geographic 
region.    
Patients and Methods    
The present study was approved by the ethics 
committee of Tehran University of Medical 
Sciences, Tehran, Iran.
In this retrospective study, histopathologic 
findings of patients who underwent any 
form of corneal transplantation other than 
endothelial keratoplasty between March 2002 
and March 2014 at Farabi Eye Hospital (a 
referral eye center in Tehran the capital city 
of Iran) were reviewed and pertinent samples 
with a confirmed diagnosis of CD were 
selected. These specimens were previously 
fixed with formalin and embedded into 
paraffin. All tissue blocks were cut at 5 micron 
sections and stained with hematoxylin and 
eosin (H&E).Specific stains were applied 
including Masson’s trichrome to diagnose 
hyaline depositions in granular corneal 
dystrophy (GCD), Alcian Blue, mucicarmine 
and Periodic Acid Schiff (PAS) to diagnose 
mucopolysaccharide accumulations in macular 
corneal dystrophy (MCD) and Congo Red 
to diagnose amyloid precipitations in lattice 
corneal dystrophy (LCD). The diagnoses were 
corroborated and classified based on the IC3D 
classification of corneal dystrophies edition 2. 
Patients’ demographics were extracted from 
their pathology records. Data were analyzed 
using SPSS software version 20 (Armonk, 
NY: IBM Corp.). In this assessment,  p values 
less than 0.05 were regarded as statistically 
significant.
Results
During the time interval of this retrospective 
analysis, between 2002  and 2014, 5867 
corneal samples were sent to the pathology 
department with diagnosis of CD made in 
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239 (4.07 %)  of samples. Among the samples 
diagnosed as CD, stromal dystrophies were 
the leading cause with 120 (50.2 %) samples, 
followed by endothelial dystrophies with 
61 (25.5 %) samples, epithelial and sub-
epithelial dystrophies with 30 (12.6 %) 
samples and finally epithelial-stromal TGFBI 
lattice dystrophies with 28 (11.7 %) samples. 
Regarding the frequency of  different types of 
CD, MCD with 117 (49 %) cases, was the most 
common type followed by Fuchs endothelial 
corneal dystrophy (FECD) with 39 (16.3 %) 
cases, gelatinous drop-like corneal dystrophy 
(GDLD) with 30 (12.6 %) cases, CHED with 
21 (8.8 %) cases, GCD type 1 (GCD1) with 13 
(5.4 %) cases, LCD with 9 (3.8 %) cases, GCD 
type 2 with 3 (1.3 %) cases and congenital 
stromal corneal dystrophy (CSCD) and PPCD 
with 1 (0.4 %) case each. In two samples, the 
clinical and pathologic evidence of Schnyder 
corneal dystrophy (SCD) existed as globular 
empty spaces in the superficial stroma that were 
probably tracks of lipid depositions previously 
dissolved during tissue processing. Ultimately, 
we reported these two slides as cases of SCD 
(Table1). When we examined the frequency of 
CDs based on the patients' gender, we observed 
that 119 (49.8 %) CD positive samples were 
female, and 120 (50.2 %) were male. In our 
study, the prevalence of GDLD was two times 
higher in females than in males (P = 0.048). 
There was no other significant relationship 
between sex and the type of dystrophy in 
our analysis. Regarding the patients’ age, 
Table 1: The prevalence of corneal dystrophies among patients entering the study





Gelatinous drop - 
like
10 (33 %) 20 (66 %) 30 (12.6 %) 25.8
Total epithelial and subepithelial 10 (33 %) 20 (66 %) 30 (12.6 %) 25.8
Epithelial - stromal 
TGFB1
Reis - Buckler 1 (33 %) 2 (66 %) 3 (1.3 %) 43.3
Lattice 7 (77.7 %) 2 (22.3 %) 9 (3.7 %) 56.1
Granular type 1 6 (46.15 %) 7 (53.85 %) 13 (5.5 %) 44.3
Granular type 2 2 (66 %) 1 (33 %) 3 (1.3 %) 50.6
 Total epithelial - stromal TGFB1 16 (57.1 %) 12 (42.9 %) 28 (11.7 %) 48.6
Stromal                            Schnyder 0 (0 %) 2 (100 %) 2 (0.9 %) 59
CSCD 1 (100 %) 0 (0 %) 1 (0.4 %) 17
Macular 65 (55.55 %) 52 (44.45 %) 117 (49 %) 36
Total stromal 66 (55 %) 54 (45 %) 120 (50.2 %) 36.2
Endothelial CHED 9 (42.86 %) 12 (57.14 %) 21 (8.8 %) 16.1
PPCD 1 (100 %) 0 (0 %) 1 (0.4 %) 31.4
Fuch’s 18 (46.15 %) 21 (53.85 %) 39 (16.3 %) 58
Total endothelial 28 (45.9 %) 33 (54.1 %) 61 (25.5 %) 43.1
Total 120 (50.2 %) 119 (49.8 %) 239 38.1
CSCD:congenital
stromal corneal dystrophy; CHED:congenital hereditary endothelial
dystrophy; PPCD: posterior polymorphous corneal dystrophy
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the highest number of corneal dystrophies 
was seen in 20 to 29 year age group, with 
59 (23.8 %) cases (Table 2) . The youngest 
and the oldest patients in our study were 
2 and 85 years old, respectively, and both 
were suffering from endothelial dystrophies. 
Considering the affected layer, patients with 
epithelial and sub-epithelial dystrophies were 
significantly younger than patients affected 
by CDs involving other layers, with a mean 
age of 25.8 years (P < 0.001). Also patients 
diagnosed with FECD had a mean age of 58 
years, and this number was significantly higher 
than other groups (P < 0.001). After patients 
with FECD, patients with LCD were older than 
other groups (P < 0.001). Also, the mean age 
of MCD patients (36 years), was significantly 
higher than that of CHED patients (16 years ; 
P < 0.001). 
Discussion
In the present study, approximately 4.07 % 
of corneal transplantation procedures were 
carried out due to CD which is comparable 
with some previous studies conducted in China 
(3.6 %) 6 and Iran (6.44 %) 14.  In other studies, 
carried out in different parts of the world, the 
frequency of CD in tissue samples obtained 
from corneal transplant surgery candidates 
ranges from 3.4 % to 13.9 %. In regions such 
as Saudi Arabia, Taiwan, Northern parts of 
China and the Shandong province of China 
CD has been reported to be responsible for 4 %, 
6.4 %, 4 %, and 3.4 % of corneal transplants, 
respectively and these frequencies are similar 
to those reported from Iran but are lower than 
those reported from European countries, the 
USA and Japan 3,6,15-21. 
Considering the relative frequency of MCD in 
corneal transplant cases, a comparable pattern 
between Iran, Saudi Arabia, and India exists 2. 2. 
MCD is a genetic entity that has an autosomal 
recessive inheritance pattern 22; therefore, the 
comparable frequencies between the three 
mentioned countries may be explained by the 
common act of consanguineous marriage in 
these regions, and this shows the importance of 
genetic counseling before and after marriage. 
In our assessment, FECD comprised 16.3 % of 
all CD cases documented. FECD displays an 
Table 2: Age Distribution of patients with corneal dystrophy undergoing corneal 
transplant




Stromal Endothelial Total number
0 - 9 4 1 0 6 13 (5.4 %)
10 - 19 3 1 10 8 26 (10.9 %)
20 - 29 12 3 31 11 59 (24.7 %)
30 - 39 7 3 30 4 41 (17.2 %)
40 - 49 4 7 26 2 40 (16.7 %)
50 - 59 0 4 19 6 25 (10.5 %)
60 - 69 0 6 3 10 19 (7.9 %)
70 - 79 0 2 0 13 13 (5.4 %)
80 - 89 0 1 1 1 3 (1.3 %)
Total number 30 28 120 61 239
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autosomal dominant inheritance pattern and 
different genes associated with the disease have 
been identified. Considering the heterogeneous 
and complex genetic nature of FECD and 
existence of sporadic cases of the disease, 
explaining for the difference in prevalence of 
the disease between different societies requires 
more studies and knowledge about the novel 
genetic aspects of FECD and its risk factors. 
The Eye Bank Association of America reported 
in 2014 that FECD is the cause for 21 % of all 
corneal transplantations in America and it is 
estimated that this dystrophy has a prevalence 
of 4 % in the total American population 23. In 
another study performed by Ghosheh et al., 5 
in the US, FECD was the underlying cause for 
10.8 % to 16.3 % of penetrating keratoplasty 
cases, and other dystrophy types were linked 
to 1 % to 1.8 % of corneal transplantations. 
Santo et al., 16 in a study conducted in Japan on 
159 corneal samples belonging to CD patients; 
reported only one confirmed case of FECD, 
which indicates the very low frequency of 
this dystrophy in Japan. Such a significant 
difference between FECD frequencies among 
corneas undergoing corneal transplant surgery 
in distinct populations could stem from the 
disparity between possibilities of the disease 
progressing towards a clinically significant 
state in populations with different genetic 
compositions. A study carried out in order to 
compare the endothelial cell density (ECD) of 
individuals between Japanese and Americans 
has indicated that ECD is significantly 
higher Japanese population 24. Given the 
fact that a decreased ECD has a role in the 
pathogenesis of FECD, this finding might give 
a justification for the lower prevalence of this 
disease in Japan. Studies in western countries 
show that the prevalence of FECD is 2.5 to 
3 times higher in women than in men, but 
this proportion was 1.16 in our study which 
indicates approximately even sex distribution 
of FECD in our study. 
Based on scientific literature, GCD is the most 
common CD 25 but the opacities caused by 
GCD have a small effect on patients’ vision, 
and therefore, a lower percentage of patients 
will need corneal transplantation compared to 
other dystrophies and those who do, will have 
the procedure at older ages. In the current 
study, two corneal samples suspicious of SCD 
existed, but the chance of reconfirming the 
diagnosis of this disease faded due to tissue 
processing and dissolution of fat deposits. 
To the best of our knowledge, the higher 
prevalence of GDLD in females undergoing 
corneal transplant observed in our study has 
not been mentioned in previous studies. It 
may necessitate deeper genetic studies on this 
special dystrophy to find if females have a more 
severe disease necessitating corneal transplant 
or the disease is more common in females in 
some areas with a distinct genetic pattern other 
than the known autosomal recessive pattern.
Conclusions
Based on our findings Macular corneal 
dystrophy was the most common corneal 
dystrophy subtype in patients scheduled for 
corneal transplantations other than endothelial 
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